Our Healthy Growth strategy is built on three focus areas: Benecol® and plant stanol ester solutions, value added oats and ingredients and plant-based products.
Our target is to grow the combined net sales from the three aforementioned focus areas by an average of 7% annually and the net sales of the entire Group by 5% annually during the strategy period 2022‒2025. Furthermore, we are targeting a comparable EBIT of over 10 per cent of the Group’s net sales in 2025.
Our strong financial standing creates a solid basis for accelerating growth during the strategy period. Although we have invested a total of nearly EUR 70 million in our production facilities and our expertise in plant-based foods and related technologies during the last three years, our financial position has remained strong.
Our goal is to reward shareholders also in the coming years of building growth and to pay an annual dividend of 50–100% of the company’s earnings per share. In addition, we aim to return value to shareholders through, for example, payment of extra dividends and other ways made possible by a strong balance sheet.